2022 / Randomized, double-blind, placebo-controlled trial
Oral shallot supplementation improved ocular symptoms in patients with allergic rhinitis receiving standard treatment.
In a randomized, double-blind, placebo-controlled trial, 16 patients with allergic rhinitis were assigned to receive cetirizine (10 mg daily) plus either 3 g of oral shallot per day or placebo capsules for 4 weeks. After 4 weeks, 62.5% of patients in the shallot group and 37.5% in the control group showed improvement in post-treatment visual analog scores of overall symptoms. Total nasal symptom scores decreased significantly in both groups without a significant between-group difference (P = 0.18), whereas total ocular symptom scores improved significantly only in the shallot group (P = 0.01). Adverse events from shallot did not differ from placebo.
Arpornchayanon W, Klinprung S, Chansakaow S, et al. Asian Pac J Allergy Immunol, 2022. PMID 31421664